Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas.

Abstract:

:Escape from immune detection favors both tumor survival and progression, and new approaches to circumvent this are essential to combat cancers. Nonvirulent, tumor-tropic bacteria, such as Salmonella typhimurium, can unmask a tumor by transforming it into a site of inflammation; however, the nonspecific invasiveness of Salmonella leads to off-target effects diluting its therapeutic efficacy and making its use in human patients inherently risky. Here, we demonstrate that Salmonella tumor specificity can be significantly improved via a surface-expressed single-domain antibody directed to a tumor-associated antigen (CD20). Antibody-dependent bacterial targeting specifies the infection of CD20+ lymphoma cells in vitro and in vivo, while significantly diminishing nonspecific cell invasion. Indeed, CD20-targeted Salmonella was less generally invasive, even in organs that normally serve as physiological reservoirs. Furthermore, tumor-specific Salmonella engineered to carry the herpes simplex virus thymidine kinase prodrug-converting enzyme effectively treats human lymphoma xenografts when coadministered intratumorally or intravenously with ganciclovir in mice lacking a functional adaptive immune system. Therefore, tumor-targeted Salmonella could prove effective even in those patients displaying a debilitated immune system, which is often the case with late-stage cancers. Altogether, antibody-displaying Salmonella vectors can mediate a tumor-specific response and rejection with few detectable adverse effects while specifically delivering cytotoxic payloads.

journal_name

Blood

journal_title

Blood

authors

Massa PE,Paniccia A,Monegal A,de Marco A,Rescigno M

doi

10.1182/blood-2012-12-474098

subject

Has Abstract

pub_date

2013-08-01 00:00:00

pages

705-14

issue

5

eissn

0006-4971

issn

1528-0020

pii

blood-2012-12-474098

journal_volume

122

pub_type

杂志文章

相关文献

BLOOD文献大全
  • A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.

    abstract::Allogeneic hematopoietic stem cell transplantation (alloHSCT) is the only potentially curative treatment available for patients with B-cell chronic lymphocytic leukemia (B-CLL). Here, we show that post-alloHSCT antibody repertoires can be mined for the discovery of fully human monoclonal antibodies to B-CLL cell-surfa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-05-222786

    authors: Baskar S,Suschak JM,Samija I,Srinivasan R,Childs RW,Pavletic SZ,Bishop MR,Rader C

    更新日期:2009-11-12 00:00:00

  • Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.

    abstract::Fas (CD95/Apo-1) mutations were previously reported as the genetic defect responsible for human lymphoproliferative syndrome associated with autoimmune manifestations (also known as autoimmune lymphoproliferative syndrome or Canale-Smith syndrome). We have identified 14 new heterozygous Fas mutations. Analysis of pati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rieux-Laucat F,Blachère S,Danielan S,De Villartay JP,Oleastro M,Solary E,Bader-Meunier B,Arkwright P,Pondaré C,Bernaudin F,Chapel H,Nielsen S,Berrah M,Fischer A,Le Deist F

    更新日期:1999-10-15 00:00:00

  • Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia.

    abstract::Human T-cell leukemia virus type-I (HTLV-I) is the etiologic agent of adult T-cell leukemia (ATL), an aggressive lymphoproliferative disease. MicroRNAs (miRNAs) are differentially expressed during hematopoiesis and lineage commitment of hematopoietic stem cell progenitors (HSCPs). Here, we report aberrant expression o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-11-189845

    authors: Bellon M,Lepelletier Y,Hermine O,Nicot C

    更新日期:2009-05-14 00:00:00

  • Increased β4GALT1 expression associates with platelet surface galactosylation and thrombopoietin plasma levels in MPNs.

    abstract::Aberrant megakaryopoiesis is a hallmark of the myeloproliferative neoplasms (MPNs), a group of clonal haematological malignancies originating from haematopoietic stem cells, leading to an increase in mature blood cells in the peripheral blood. Sialylated derivatives of the glycan structure β4-N-acetyllactosamine (Galβ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020007265

    authors: Di Buduo CA,Giannini S,Abbonante V,Rosti V,Hoffmeister K,Balduini A

    更新日期:2020-11-25 00:00:00

  • A novel form of complete IL-12/IL-23 receptor beta1 deficiency with cell surface-expressed nonfunctional receptors.

    abstract::Complete interleukin-12/interleukin-23 receptor beta1 (IL-12Rbeta1) deficiency is the most frequent known genetic etiology of the syndrome of Mendelian susceptibility to mycobacterial disease. The patients described to date lack IL-12Rbeta1 at the surface of their natural killer (NK) and T cells due to IL12RB1 mutatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0584

    authors: Fieschi C,Bosticardo M,de Beaucoudrey L,Boisson-Dupuis S,Feinberg J,Santos OF,Bustamante J,Levy J,Candotti F,Casanova JL

    更新日期:2004-10-01 00:00:00

  • The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcgamma receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors.

    abstract::Molecular mechanisms by which the Src homology 2 domain-containing inositol 5-phosphatase (SHIP) negatively regulates phagocytosis in macrophages are unclear. We addressed the issue using bone marrow-derived macrophages from FcgammaR- or SHIP-deficient mice. Phagocytic activities of macrophages from FcgammaRII(b)(-/-)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-03-0787

    authors: Nakamura K,Malykhin A,Coggeshall KM

    更新日期:2002-11-01 00:00:00

  • G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.

    abstract::Src activation involves the coordinated regulation of positive and negative tyrosine phosphorylation sites. The mechanism whereby receptor tyrosine kinases, cytokine receptors, and integrins activate Src is not known. Here, we demonstrate that granulocyte colony-stimulating factor (G-CSF) activates Lyn, the predominan...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-12-261636

    authors: Futami M,Zhu QS,Whichard ZL,Xia L,Ke Y,Neel BG,Feng GS,Corey SJ

    更新日期:2011-07-28 00:00:00

  • Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.

    abstract::The adoptive transfer of donor T cells that recognize recipient minor histocompatibility antigens (mHAgs) is a potential strategy for preventing or treating leukemic relapse after allogeneic hematopoietic cell transplantation (HCT). A total of 7 patients with recurrent leukemia after major histocompatibility complex (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-10-248997

    authors: Warren EH,Fujii N,Akatsuka Y,Chaney CN,Mito JK,Loeb KR,Gooley TA,Brown ML,Koo KK,Rosinski KV,Ogawa S,Matsubara A,Appelbaum FR,Riddell SR

    更新日期:2010-05-13 00:00:00

  • Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor.

    abstract::A microperfusion system containing a glass capillary, the inner surface of which is coated with a phospholipid bilayer containing tissue factor, was used to explore the requirement for factors VIIa and Xa in the complex formed with the lipoprotein-associated coagulation inhibitor (LACI). Various combinations of factor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gemmell CH,Broze GJ Jr,Turitto VT,Nemerson Y

    更新日期:1990-12-01 00:00:00

  • Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity.

    abstract::Regulatory molecules produced by stromal cells are often membrane bound until cleaved by matrix metalloproteinases (MMPs); cleavage can either activate or inactivate regulatory functions. We report here that marrow stromal cells induce the expression of MMP-9 in monocytes. Induction was contact independent and could b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-020289

    authors: Iwata M,Pillai M,Ramakrishnan A,Hackman RC,Deeg HJ,Opdenakker G,Torok-Storb B

    更新日期:2007-01-01 00:00:00

  • Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.

    abstract::The aim of this study was to understand the impact of chronic graft-versus-host disease (cGVHD) on the overall health status of hematopoietic cell transplantation (HCT) survivors. Subjects included 584 individuals who had undergone allogeneic HCT between 1976 and 1999, survived 2 or more years, and completed a 255-ite...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-003954

    authors: Fraser CJ,Bhatia S,Ness K,Carter A,Francisco L,Arora M,Parker P,Forman S,Weisdorf D,Gurney JG,Baker KS

    更新日期:2006-10-15 00:00:00

  • Pseudo-Bernard-Soulier syndrome: thrombocytopenia caused by autoantibody to platelet glycoprotein Ib.

    abstract::The Bernard-Soulier syndrome is an inherited bleeding disorder that is due to a deficiency in platelet glycoprotein Ib. Bernard-Soulier platelets fail to agglutinate in response to ristocetin despite normal levels of factor VIII:von Willebrand factor. We report a patient who developed severe refractory thrombocytopeni...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Devine DV,Currie MS,Rosse WF,Greenberg CS

    更新日期:1987-08-01 00:00:00

  • The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes.

    abstract::We have used (cryo) electron tomography to provide a 3-dimensional (3D) map of the intracellular membrane organization of human platelets at high spatial resolution. Our study shows that the open canalicular system and dense tubular system are highly intertwined and form close associations in specialized membrane regi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-02-268680

    authors: van Nispen tot Pannerden H,de Haas F,Geerts W,Posthuma G,van Dijk S,Heijnen HF

    更新日期:2010-08-19 00:00:00

  • Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes.

    abstract::Therapeutic gene delivery to hematopoietic stem cells (HSCs) holds great potential as a life-saving treatment of monogenic, oncologic, and infectious diseases. However, clinical gene therapy is severely limited by intrinsic HSC resistance to modification with lentiviral vectors (LVs), thus requiring high doses or repe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000040

    authors: Ozog S,Timberlake ND,Hermann K,Garijo O,Haworth KG,Shi G,Glinkerman CM,Schefter LE,D'Souza S,Simpson E,Sghia-Hughes G,Carillo RR,Boger DL,Kiem HP,Slukvin I,Ryu BY,Sorrentino BP,Adair JE,Snyder SA,Compton AA,Torbet

    更新日期:2019-10-17 00:00:00

  • SH2 domain-mediated targeting, but not localization, of Syk in the plasma membrane is critical for FcepsilonRI signaling.

    abstract::Aggregation of the high-affinity IgE receptor induces the tyrosine phosphorylation of subunits of the receptor and the subsequent association with the receptor of the cytosolic protein tyrosine kinase Syk. The current experiments examined the functional importance of membrane association of Syk and the role of the SH2...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.5.1352

    authors: Sada K,Zhang J,Siraganian RP

    更新日期:2001-03-01 00:00:00

  • High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

    abstract::Single-center experiences have shown that intensified treatments with autologous transplantation are a promising therapeutic strategy for patients with high-risk follicle-center lymphoma (FCL) at diagnosis, whereas data from prospective multicenter trials are still lacking. This paper describes the results of a prospe...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2002-02-0621

    authors: Ladetto M,Corradini P,Vallet S,Benedetti F,Vitolo U,Martelli M,Brugiatelli M,Coser P,Perrotti A,Majolino I,Fioritoni G,Morandi S,Musso M,Zambello R,Chisesi T,Di Renzo N,Vivaldi P,De Crescenzo A,Gallamini A,Salvi F,

    更新日期:2002-09-01 00:00:00

  • Vav1, but not Vav2, contributes to platelet aggregation by CRP and thrombin, but neither is required for regulation of phospholipase C.

    abstract::We have investigated the role of the Rho and Rac family small guanine triphosphate (GTP) exchange factors (RhoGEFs), Vav1 and Vav2, in the activation of platelets by the immunoreceptor tyrosine-based activation motif (ITAM)-coupled collagen receptor GPVI and by the G protein-coupled receptor agonist thrombin. The glyc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.V100.10.3561

    authors: Pearce AC,Wilde JI,Doody GM,Best D,Inoue O,Vigorito E,Tybulewicz VL,Turner M,Watson SP

    更新日期:2002-11-15 00:00:00

  • EZH2 mutational status predicts poor survival in myelofibrosis.

    abstract::We genotyped 370 subjects with primary myelofibrosis (PMF) and 148 with postpolycythemia vera/postessential thrombocythemia (PPV/PET) MF for mutations of EZH2. Mutational status at diagnosis was correlated with hematologic parameters, clinical manifestations, and outcome. A total of 25 different EZH2 mutations were de...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-363424

    authors: Guglielmelli P,Biamonte F,Score J,Hidalgo-Curtis C,Cervantes F,Maffioli M,Fanelli T,Ernst T,Winkelman N,Jones AV,Zoi K,Reiter A,Duncombe A,Villani L,Bosi A,Barosi G,Cross NC,Vannucchi AM

    更新日期:2011-11-10 00:00:00

  • Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia.

    abstract::To characterize genetic contributions toward aberrant splicing of the hyaluronan synthase 1 (HAS1) gene in multiple myeloma (MM) and Waldenstrom macroglobulinemia (WM), we sequenced 3616 bp in HAS1 exons and introns involved in aberrant splicing, from 17 patients. We identified a total of 197 HAS1 genetic variations (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-02-141770

    authors: Adamia S,Reichert AA,Kuppusamy H,Kriangkum J,Ghosh A,Hodges JJ,Pilarski PM,Treon SP,Mant MJ,Reiman T,Belch AR,Pilarski LM

    更新日期:2008-12-15 00:00:00

  • Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells.

    abstract::Endothelial cells (ECs) express 2 members of the cadherin family, VE and N-cadherin. Although VE-cadherin induces EC homotypic adhesion, N-cadherin function in ECs remains largely unknown. EC-specific inactivation of either VE or N-cadherin leads to early fetal lethality suggesting that these cadherins play a nonredun...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-09-381012

    authors: Giampietro C,Taddei A,Corada M,Sarra-Ferraris GM,Alcalay M,Cavallaro U,Orsenigo F,Lampugnani MG,Dejana E

    更新日期:2012-03-01 00:00:00

  • An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand.

    abstract::Identification of receptor activator of nuclear factor-kappaB (RANK) and RANK-ligand (RANKL) has provided new insights into the osteoclast differentiation pathway. Osteoclast precursor cells were isolated using monoclonal antibodies against c-Fms and RANK, and the effect of adherence on the in vitro differentiation an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miyamoto T,Arai F,Ohneda O,Takagi K,Anderson DM,Suda T

    更新日期:2000-12-15 00:00:00

  • Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver.

    abstract::Expression of the CD4 antigen was observed on human fetal liver, fetal bone marrow (BM), and umbilical cord blood progenitors expressing high levels of CD34. Using clonal and liquid-culture assays, CD4+ CD34++ Lin- (lineage = CD3, CD8, CD10, CD14, CD15, CD16, CD19, CD20, and glycophorin A) fetal liver progenitors were...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Muench MO,Roncarolo MG,Namikawa R

    更新日期:1997-02-15 00:00:00

  • Deletion of the zinc-binding motif of CD13/aminopeptidase N molecules results in loss of epitopes that mediate binding of inhibitory antibodies.

    abstract::The myeloid cell-surface glycoprotein CD13/aminopeptidase N (APN; EC 3.4.11.2) contains a pentapeptide (HExxH) in its extracellular domain that is characteristic of many zinc-dependent metalloproteinases. This region contains residues important for zinc binding and constitutes part of the catalytic domain of several m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ashmun RA,Shapiro LH,Look AT

    更新日期:1992-06-15 00:00:00

  • Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?

    abstract::Recent studies have reported that the pharmacokinetics of high-dose busulfan in bone marrow transplantation (BMT) are age-dependent: with the usual dosage of 16 mg/kg over 4 days, systemic exposure is two to four times lower in children than in adults. Data suggested that the dose of busulfan should rather be calculat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Vassal G,Deroussent A,Challine D,Hartmann O,Koscielny S,Valteau-Couanet D,Lemerle J,Gouyette A

    更新日期:1992-05-01 00:00:00

  • ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

    abstract::The International Peripheral T-Cell Lymphoma Project is a collaborative effort designed to gain better understanding of peripheral T-cell and natural killer (NK)/T-cell lymphomas (PTCLs). A total of 22 institutions in North America, Europe, and Asia submitted clinical and pathologic information on PTCLs diagnosed and ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2008-01-134270

    authors: Savage KJ,Harris NL,Vose JM,Ullrich F,Jaffe ES,Connors JM,Rimsza L,Pileri SA,Chhanabhai M,Gascoyne RD,Armitage JO,Weisenburger DD,International Peripheral T-Cell Lymphoma Project.

    更新日期:2008-06-15 00:00:00

  • Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.

    abstract::Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML) remains a life-threatening malignancy in children, with current survival rates of ∼70%. State-of-the-art recommendations in adult AML have recently been published in this journal by Döhner et al. The primary goal of an internatio...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-03-362608

    authors: Creutzig U,van den Heuvel-Eibrink MM,Gibson B,Dworzak MN,Adachi S,de Bont E,Harbott J,Hasle H,Johnston D,Kinoshita A,Lehrnbecher T,Leverger G,Mejstrikova E,Meshinchi S,Pession A,Raimondi SC,Sung L,Stary J,Zwaan CM,K

    更新日期:2012-10-18 00:00:00

  • Smad7 promotes self-renewal of hematopoietic stem cells.

    abstract::The Smad-signaling pathway downstream of the transforming growth factor-beta superfamily of ligands is an evolutionarily conserved signaling circuitry with critical functions in a wide variety of biologic processes. To investigate the role of this pathway in the regulation of hematopoietic stem cells (HSCs), we have b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-005611

    authors: Blank U,Karlsson G,Moody JL,Utsugisawa T,Magnusson M,Singbrant S,Larsson J,Karlsson S

    更新日期:2006-12-15 00:00:00

  • Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice.

    abstract::BRCA1 is critical for maintenance of genomic stability and interacts directly with several proteins that regulate hematopoietic stem cell function and are part of the Fanconi anemia (FA) double-strand break DNA repair pathway. The effects of complete BRCA1 deficiency on bone marrow (BM) function are unknown. To test t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-03-635599

    authors: Vasanthakumar A,Arnovitz S,Marquez R,Lepore J,Rafidi G,Asom A,Weatherly M,Davis EM,Neistadt B,Duszynski R,Vardiman JW,Le Beau MM,Godley LA,Churpek JE

    更新日期:2016-01-21 00:00:00

  • A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells.

    abstract::An unmet need in cell engineering is the availability of a single transgene encoded, functionally inert, human polypeptide that can serve multiple purposes, including ex vivo cell selection, in vivo cell tracking, and as a target for in vivo cell ablation. Here we describe a truncated human EGFR polypeptide (huEGFRt) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-337360

    authors: Wang X,Chang WC,Wong CW,Colcher D,Sherman M,Ostberg JR,Forman SJ,Riddell SR,Jensen MC

    更新日期:2011-08-04 00:00:00

  • Murine myeloid cells transformed by myb require fibroblast-derived or autocrine growth factors in addition to granulocyte-macrophage colony-stimulating factor for proliferation.

    abstract::Murine myeloid cells can be transformed in vitro by infection with recombinant retroviruses carrying activated myb genes. While these myb-transformed hematopoietic cells (MTHCs) can proliferate continuously in culture, they exhibit several characteristics of progenitor cells of the granulocyte-macrophage (GM) lineage,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Macmillan EM,Gonda TJ

    更新日期:1994-01-01 00:00:00